PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+8.31%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$395M
AUM Growth
+$395M
(-14%)
Cap. Flow
-$66.6M
Cap. Flow
% of AUM
-16.84%
Top 10 Holdings %
Top 10 Hldgs %
40.77%
Holding
93
New
11
Increased
18
Reduced
29
Closed
19
Top Buys
| 1 |
AbbVie
ABBV
|
$8.09M |
| 2 |
Fulcrum Therapeutics
FULC
|
$5.43M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$4.67M |
| 4 |
Immunic
IMUX
|
$4.51M |
| 5 |
Amgen
AMGN
|
$4.25M |
Top Sells
| 1 |
Intuitive Surgical
ISRG
|
$18M |
| 2 |
Charles River Laboratories
CRL
|
$11.2M |
| 3 |
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
|
$7.96M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$7.54M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$5.93M |
Sector Composition
| 1 | Healthcare | 97.83% |
| 2 | Industrials | 0.81% |
| 3 | Technology | 0.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Stereotaxis
STXS
$246M
| $2.42M | 0.61% |
450,000
-229,082
| -34% | -$1.23M |
|
52
Veracyte
VCYT
$2.41B
| $2.09M | 0.53% |
+45,000
| New | +$2.09M |
|
53
Alpha Teknova
TKNO
$227M
| $2.03M | 0.51% |
+81,372
| New | +$2.03M |
|
54
Altimmune
ALT
$325M
| $1.98M | 0.5% |
175,000
-25,000
| -13% | -$283K |
|
55
iRhythm Technologies
IRTC
$5.67B
| $1.9M | 0.48% |
+32,500
| New | +$1.9M |
|
|
SURF
56
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $1.88M | 0.48% |
248,267
+20,000
| +9% | +$151K |
|
57
Schrodinger
SDGR
$1.42B
| $1.81M | 0.46% |
33,108
+2,500
| +8% | +$137K |
|
|
SCTL
58
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $1.59M | 0.4% |
770,833
| – | – |
|
59
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.47M | 0.37% |
101,961
-250,000
| -71% | -$3.59M |
|
60
TELA Bio
TELA
$65.4M
| $1.37M | 0.35% |
100,000
| – | – |
|
|
ONCT
61
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $1.36M | 0.34% |
16,269
-4,500
| -22% | -$375K |
|
|
ICAD
62
DELISTED
iCAD Inc
ICAD
| $1.34M | 0.34% |
125,000
-406,255
| -76% | -$4.37M |
|
|
BLRX
63
BioLineRX
BLRX
$15.5M
| $1.13M | 0.29% |
10,277
-8,074
| -44% | -$888K |
|
64
MannKind Corp
MNKD
$1.69B
| $1.11M | 0.28% |
255,047
-550,000
| -68% | -$2.39M |
|
65
Vericel Corp
VCEL
$1.69B
| $993K | 0.25% |
20,340
| – | – |
|
|
MTEM
66
DELISTED
Molecular Templates, Inc.
MTEM
| $951K | 0.24% |
9,444
| – | – |
|
|
CSLT
67
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $942K | 0.24% |
600,000
-77,734
| -11% | -$122K |
|
68
Zymeworks
ZYME
$1.07B
| $871K | 0.22% |
+30,000
| New | +$871K |
|
|
OPNT
69
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $772K | 0.2% |
+30,000
| New | +$772K |
|
70
KORU Medical Systems
KRMD
$187M
| $645K | 0.16% |
226,256
+25,000
| +12% | +$71.3K |
|
71
Gyre Therapeutics
GYRE
$734M
| $548K | 0.14% |
17,793
-34,667
| -66% | -$1.07M |
|
72
Verastem
VSTM
$585M
| $541K | 0.14% |
14,650
+4,167
| +40% | +$154K |
|
73
Vera Therapeutics
VERA
$1.47B
| $445K | 0.11% |
25,638
-50,000
| -66% | -$868K |
|
|
CALA
74
DELISTED
Calithera Biosciences, Inc
CALA
| $219K | 0.06% |
5,031
| – | – |
|
75
Aurinia Pharmaceuticals
AUPH
$1.58B
| – | – |
-49,969
| Closed | -$648K |
|